Companies / BOC Sciences / Margetuximab
BOC Sciences

Margetuximab | BOC Sciences

Margetuximab is an anti-HER2 monoclonal antibody, which has been used for the treatment of adult patients with HER2-positive (HER2+) metastatic breast cancer.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.